Literature DB >> 11081912

Diagnosis and management of left ventricular assist device valve-endocarditis: LVAD valve replacement.

K C de Jonge1, H R Laube, P M Dohmen, V Ivancevic, W F Konertz.   

Abstract

A 57-year-old man who has been wearing a Novacor N100 left ventricular assist device (LVAD) for more than 3 years suffered from LVAD endocarditis. Only by immunoscintigraphic methods was it possible to localize the septic focus. After successful exchange of in- and outflow tract valves, the infection was eradicated. Microscopic investigation confirmed the scintigraphic findings: Gram-positive bacteria were found. The valves showed no gross degenerative lesions after more than 1,100 days of implantation. The patient is now doing well.

Entities:  

Mesh:

Year:  2000        PMID: 11081912     DOI: 10.1016/s0003-4975(00)01525-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Impact of adverse events on ventricular assist device outcomes.

Authors:  Aleksandar Adzic; Snehal R Patel; Simon Maybaum
Journal:  Curr Heart Fail Rep       Date:  2013-03

2.  A reliable test to detect impending pump failure during long-term support on the Novacor N100 Left Ventricular Assist System.

Authors:  P M Dohmen; H Laube; K de Jonge; W Konertz
Journal:  Tex Heart Inst J       Date:  2001

Review 3.  Role of gallium SPECT-CT in the diagnosis of left ventricular assist device infections.

Authors:  Dana T Levy; Grace Y Minamoto; Raphaella Da Silva; Yoram A Puius; Naomi Peck; Daniel Goldstein; David D'Alessandro; Victoria A Muggia
Journal:  ASAIO J       Date:  2015 Jan-Feb       Impact factor: 2.872

Review 4.  Endocarditis in left ventricular assist device.

Authors:  Braghadheeswar Thyagarajan; Monisha Priyadarshini Kumar; Rutuja R Sikachi; Abhinav Agrawal
Journal:  Intractable Rare Dis Res       Date:  2016-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.